Since ABCB5 represents a potential chemoresistance mechanism [36], GEPhighABCB5+ hepatic CSCs might be responsible for both initiation and chemotherapeutic refractoriness of HCC. Here, ABCB5 is linked to hepatocellular carcinoma.